These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 19169123)

  • 1. Adherence to quality indicators and survival in patients with breast cancer.
    Cheng SH; Wang CJ; Lin JL; Horng CF; Lu MC; Asch SM; Hilborne LH; Liu MC; Chen CM; Huang AT
    Med Care; 2009 Feb; 47(2):217-25. PubMed ID: 19169123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer.
    Hébert-Croteau N; Brisson J; Lemaire J; Latreille J; Pineault R
    Cancer; 2005 Oct; 104(7):1343-8. PubMed ID: 16080144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using a bubble chart to enhance adherence to quality-of-care guidelines for colorectal cancer patients.
    Chien TW; Lin YF; Chang CH; Tsai MT; Uen YH
    Eur J Cancer Care (Engl); 2012 Nov; 21(6):712-21. PubMed ID: 22335545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer?
    Wang J; Kulaylat M; Rockette H; Hassett J; Rajput A; Dunn KB; Dayton M
    Ann Surg; 2009 Apr; 249(4):559-63. PubMed ID: 19300237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States?
    Malin JL; Schneider EC; Epstein AM; Adams J; Emanuel EJ; Kahn KL
    J Clin Oncol; 2006 Feb; 24(4):626-34. PubMed ID: 16401682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of preoperative short course famotidine on TILs and survival in breast cancer.
    Parshad R; Hazrah P; Kumar S; Gupta SD; Ray R; Bal S
    Indian J Cancer; 2005; 42(4):185-90. PubMed ID: 16391436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Benchmarking: how to measure outcome quality at the comprehensive oncology centre in Stuttgart].
    Meisner C; Brinkmann F; Henke D; Junack C; Faisst S; Heidemann E
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(5):365-70. PubMed ID: 21767795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
    Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
    Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the levonorgestrel-releasing intrauterine system in breast cancer patients.
    Trinh XB; Tjalma WA; Makar AP; Buytaert G; Weyler J; van Dam PA
    Fertil Steril; 2008 Jul; 90(1):17-22. PubMed ID: 17706209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment choice and quality of care for men with localized prostate cancer.
    Miller DC; Spencer BA; Ritchey J; Stewart AK; Dunn RL; Sandler HM; Wei JT; Litwin MS
    Med Care; 2007 May; 45(5):401-9. PubMed ID: 17446826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficiency versus quality in the NHS, in Portugal: methodologies for evaluation].
    Giraldes Mdo R
    Acta Med Port; 2008; 21(5):397-410. PubMed ID: 19187682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of guideline-compliant therapy on the survival of primary breast cancer patients with: results of a retrospective cohort study].
    Wolters R; Wöckel A; Wischnewsky M; Kreienberg R
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(6):468-75. PubMed ID: 21843852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer.
    Dew JE; Wren BG; Eden JA
    Climacteric; 2003 Mar; 6(1):45-52. PubMed ID: 12725664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in health-related quality of life may predict recurrent breast cancer.
    Kenne Sarenmalm E; Odén A; Ohlén J; Gaston-Johansson F; Holmberg SB
    Eur J Oncol Nurs; 2009 Dec; 13(5):323-9. PubMed ID: 19596212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing and measuring a set of process and outcome indicators for breast cancer.
    Stordeur S; Vrijens F; Devriese S; Beirens K; Van Eycken E; Vlayen J
    Breast; 2012 Jun; 21(3):253-60. PubMed ID: 22056787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in manganese superoxide dismutase, myeloperoxidase and glutathione-S-transferase and survival after treatment for metastatic breast cancer.
    Bewick MA; Conlon MS; Lafrenie RM
    Breast Cancer Res Treat; 2008 Sep; 111(1):93-101. PubMed ID: 17922231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifocal breast cancer in women < or =35 years old.
    Litton JK; Eralp Y; Gonzalez-Angulo AM; Broglio K; Uyei A; Hortobagyi GN; Arun B
    Cancer; 2007 Oct; 110(7):1445-50. PubMed ID: 17676585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The survival impact of the choice of surgical procedure after ipsilateral breast cancer recurrence.
    Chen SL; Martinez SR
    Am J Surg; 2008 Oct; 196(4):495-9. PubMed ID: 18809050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival impact of integrative cancer care in advanced metastatic breast cancer.
    Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J
    Breast J; 2009; 15(4):357-66. PubMed ID: 19470134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.